Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Phase 1/2 × 3-(4-((4-chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid × 30 days × Clear all

Sponsor

Interventions

pembrolizumab 46 Carboplatin 35 Specimen Handling 32 Magnetic Resonance Spectroscopy 28 Biopsy 28 Cyclophosphamide 24 Nivolumab 20 Bevacizumab 19 venetoclax 18 Gemcitabine 18 Pemetrexed 17 Paclitaxel 17 Dexamethasone 17 fludarabine 16 Temozolomide 14 Cisplatin 14 Rituximab 12 Azacitidine 12 atezolizumab 11 Prednisone 11 Lenalidomide 11 Cetuximab 11 Fulvestrant 10 Vincristine 9 Irinotecan 9 X-Rays 8 Oxaliplatin 8 130-nm albumin-bound paclitaxel 8 tocilizumab 7 fludarabine phosphate 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡